These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 25861752)
1. Involvement of multiple cellular pathways in regulating resistance to tamoxifen in BIK-suppressed MCF-7 cells. Viedma-Rodríguez R; Ruiz Esparza-Garrido R; Baiza-Gutman LA; Velázquez-Flores MÁ; García-Carrancá A; Salamanca-Gómez F; Arenas-Aranda D Tumour Biol; 2015 Sep; 36(9):6991-7005. PubMed ID: 25861752 [TBL] [Abstract][Full Text] [Related]
2. Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF-7 breast cancer cells. Viedma-Rodriguez R; Baiza-Gutman LA; García-Carrancá A; Moreno-Fierros L; Salamanca-Gómez F; Arenas-Aranda D Int J Oncol; 2013 Dec; 43(6):1777-86. PubMed ID: 24100375 [TBL] [Abstract][Full Text] [Related]
3. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells. Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106 [TBL] [Abstract][Full Text] [Related]
4. Silencing of MicroRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells. Yu X; Li R; Shi W; Jiang T; Wang Y; Li C; Qu X Biomed Pharmacother; 2016 Feb; 77():37-44. PubMed ID: 26796263 [TBL] [Abstract][Full Text] [Related]
5. The oncolytic herpes simplex virus vector, G47Δ, effectively targets tamoxifen-resistant breast cancer cells. Fan J; Jiang H; Cheng L; Liu R Oncol Rep; 2016 Mar; 35(3):1741-9. PubMed ID: 26718317 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of proliferation of estrogen receptor‑positive MCF‑7 human breast cancer cells by tamoxifen through c‑Jun transcription factors. Xu Y; Zou ST; Zhu R; Li W; Gu CW; Wei SH; Xie JM; Wu HR Mol Med Rep; 2013 Apr; 7(4):1283-7. PubMed ID: 23404426 [TBL] [Abstract][Full Text] [Related]
7. Dose-dependent effect of tamoxifen in tamoxifen-resistant breast cancer cells via stimulation by the ERK1/2 and AKT signaling pathways. Wang LJ; Han SX; Bai E; Zhou X; Li M; Jing GH; Zhao J; Yang AG; Zhu Q Oncol Rep; 2013 Apr; 29(4):1563-9. PubMed ID: 23338782 [TBL] [Abstract][Full Text] [Related]
8. The role of captopril and losartan in prevention and regression of tamoxifen-induced resistance of breast cancer cell line MCF-7: an in vitro study. Namazi S; Rostami-Yalmeh J; Sahebi E; Jaberipour M; Razmkhah M; Hosseini A Biomed Pharmacother; 2014 Jun; 68(5):565-71. PubMed ID: 24975086 [TBL] [Abstract][Full Text] [Related]
9. Modulation of BAG-1 expression alters the sensitivity of breast cancer cells to tamoxifen. Liu H; Lu S; Gu L; Gao Y; Wang T; Zhao J; Rao J; Chen J; Hao X; Tang SC Cell Physiol Biochem; 2014; 33(2):365-74. PubMed ID: 24557447 [TBL] [Abstract][Full Text] [Related]
10. Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression. Zhang B; Zhang X; Tang B; Zheng P; Zhang Y Breast Cancer Res Treat; 2012 Nov; 136(2):399-406. PubMed ID: 23053650 [TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor-α variant, ER-α36, is involved in tamoxifen resistance and estrogen hypersensitivity. Zhang X; Wang ZY Endocrinology; 2013 Jun; 154(6):1990-8. PubMed ID: 23546601 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of TMEM47 Induces Tamoxifen Resistance in Human Breast Cancer Cells. Men X; Su M; Ma J; Mou Y; Dai P; Chen C; Cheng XA Technol Cancer Res Treat; 2021; 20():15330338211004916. PubMed ID: 33745390 [TBL] [Abstract][Full Text] [Related]
13. [Suppression of long non-coding RNA CCAT2 improves tamoxifen-resistant breast cancer cells' response to tamoxifen]. Cai Y; He J; Zhang D Mol Biol (Mosk); 2016; 50(5):821-827. PubMed ID: 27830684 [TBL] [Abstract][Full Text] [Related]
14. A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells. Wang B; Li D; Rodriguez-Juarez R; Farfus A; Storozynsky Q; Malach M; Carpenter E; Filkowski J; Lykkesfeldt AE; Kovalchuk O BMC Cancer; 2018 Aug; 18(1):817. PubMed ID: 30103729 [TBL] [Abstract][Full Text] [Related]
15. In Vitro and In Vivo Effects of Jia-Wei-Xiao-Yao-San in Human Breast Cancer MCF-7 Cells Treated With Tamoxifen. Chen JL; Chang CJ; Wang JY; Wen CS; Tseng LM; Chang WC; Noomhorm N; Liu HJ; Chen WS; Chiu JH; Shyr YM Integr Cancer Ther; 2014 May; 13(3):226-39. PubMed ID: 24525674 [TBL] [Abstract][Full Text] [Related]
16. Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy. Osipo C; Gajdos C; Cheng D; Jordan VC J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):249-56. PubMed ID: 15860267 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of Choline Kinase-Alpha Enhances Autophagy in Tamoxifen-Resistant Breast Cancer Cells. Kim HS; Tian L; Jung M; Choi SK; Sun Y; Kim H; Moon WK PLoS One; 2015; 10(10):e0141110. PubMed ID: 26496360 [TBL] [Abstract][Full Text] [Related]
18. Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells. Berstein LM; Yue W; Wang JP; Santen RJ Breast Cancer Res Treat; 2011 Jul; 128(1):109-17. PubMed ID: 20683653 [TBL] [Abstract][Full Text] [Related]
19. [Effect of Evn-50 on cell growth and apoptosis in tamoxifen-resistance human breast cancer cell line MCF-7/TAM-R]. Hu HY; Zhou J; Wan F; Dong LF; Zhang F; Wang YK; Chen FF; Chen YD Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 41(5):498-505. PubMed ID: 23086641 [TBL] [Abstract][Full Text] [Related]
20. Hesperidin, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells. Khamis AAA; Ali EMM; El-Moneim MAA; Abd-Alhaseeb MM; El-Magd MA; Salim EI Biomed Pharmacother; 2018 Sep; 105():1335-1343. PubMed ID: 30021371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]